Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.
Rabbani PS, Ellison T, Waqas B, Sultan D, Abdou S, David JA, Cohen JM, Gomez-Viso A, Lam G, Kim C, Thomson J, Ceradini DJ.
Rabbani PS, et al. Among authors: waqas b.
Diabetes Res Clin Pract. 2018 May;139:11-23. doi: 10.1016/j.diabres.2018.02.021. Epub 2018 Feb 21.
Diabetes Res Clin Pract. 2018.
PMID: 29476889